AzurRx BioPharma Inc (AZRX):企業の財務・戦略的SWOT分析

◆英語タイトル:AzurRx BioPharma Inc (AZRX) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH2336081FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年1月
◆ページ数:39
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥27,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥41,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

AzurRx BioPharma Inc (AZRX) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

AzurRx BioPharma Inc (AzurRx BioPharma) is a development stage biopharmaceutical company which focuses on non-systemic biologics for the treatment of patients with gastrointestinal disorders. The company’s products under development include MS1819, a non-systemic yeast recombinant enzyme intended for the treatment of exocrine pancreatic insufficiency exocrine (EPI) in patients with cystic fibrosis (CF) and chronic pancreatitis (CP). MS1819 completed phase IIa trial in partnership with Mayoly which is a European Pharmaceutical company. Its pre-clinical products include AZX1103 and AZX1101 which is recombinant beta lactamases enzyme for the prevention of nosocomial (hospital-acquired) infections and antibiotic-associated diarrhea. The company has operations in France and the US. AzurRx BioPharma is headquartered in Brooklyn, New York, the US.

AzurRx BioPharma Inc Key Recent Developments

Oct 21,2020: AzurRx BioPharma announces formation of scientific advisory board
Jul 15,2020: AzurRx BioPharma: Departure of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officers.
Apr 21,2020: AzurRx BioPharma receives loan under Paycheck Protection Program
Mar 02,2020: AzurRx BioPharma receives $1.13 million in 2018 CIR (French Research Tax Credit)
Jan 03,2020: AzurRx BioPharma announces appointment of Daniel Schneiderman as Chief Financial Officer

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
AzurRx BioPharma Inc – Key Facts
AzurRx BioPharma Inc – Key Employees
AzurRx BioPharma Inc – Key Employee Biographies
AzurRx BioPharma Inc – Major Products and Services
AzurRx BioPharma Inc – History
AzurRx BioPharma Inc – Company Statement
AzurRx BioPharma Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
AzurRx BioPharma Inc – Business Description
AzurRx BioPharma Inc – SWOT Analysis
SWOT Analysis – Overview
AzurRx BioPharma Inc – Strengths
AzurRx BioPharma Inc – Weaknesses
AzurRx BioPharma Inc – Opportunities
AzurRx BioPharma Inc – Threats
AzurRx BioPharma Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
AzurRx BioPharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
AzurRx BioPharma Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
AzurRx BioPharma Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Oct 21, 2020: AzurRx BioPharma announces formation of scientific advisory board
Jul 15, 2020: AzurRx BioPharma: Departure of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officers.
Apr 21, 2020: AzurRx BioPharma receives loan under Paycheck Protection Program
Mar 02, 2020: AzurRx BioPharma receives $1.13 million in 2018 CIR (French Research Tax Credit)
Jan 03, 2020: AzurRx BioPharma announces appointment of Daniel Schneiderman as Chief Financial Officer
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
AzurRx BioPharma Inc, Key Facts
AzurRx BioPharma Inc, Key Employees
AzurRx BioPharma Inc, Key Employee Biographies
AzurRx BioPharma Inc, Major Products and Services
AzurRx BioPharma Inc, History
AzurRx BioPharma Inc, Subsidiaries
AzurRx BioPharma Inc, Key Competitors
AzurRx BioPharma Inc, Ratios based on current share price
AzurRx BioPharma Inc, Annual Ratios
AzurRx BioPharma Inc, Annual Ratios (Cont...1)
AzurRx BioPharma Inc, Interim Ratios
AzurRx BioPharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
AzurRx BioPharma Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
AzurRx BioPharma Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[AzurRx BioPharma Inc (AZRX):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Green Earth Technologies Inc (GETG):企業の財務・戦略的SWOT分析
    Summary Green Earth Technologies Inc (GET) is a clean technology company that develops and markets of bio-based performance and cleaning products. The company’s products include small engine oils, motor oils, lubrication and engine protection oils. It also provides wheel cleaner, hydrophobic car was …
  • TOLMAR Inc-製薬・医療分野:企業M&A・提携分析
    Summary TOLMAR Inc (TOLMAR), a subsidiary of Tolmar Holding Inc is a developer, manufacturer and distributor of pharmaceutical products. The company provides generic dermatology products such as creams, gels, ointments and solutions. It also provides levetiracetam oral solutions including antiepilep …
  • Cielo Wind Power, LP-エネルギー分野:企業M&A・提携分析
    Summary Cielo Wind Power, LP (Cielo Wind) is a wind power project development company. It designs, develops, owns and operates utility-grade wind power projects. The company provides a wide range of services including engineering, construction, operations and maintenance, land procurement, meteorolo …
  • Barnes Group Inc.:企業の戦略・SWOT・財務情報
    Barnes Group Inc. - Strategy, SWOT and Corporate Finance Report Summary Barnes Group Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Smith & Williamson Holdings Ltd:企業の戦略的SWOT分析
    Smith & Williamson Holdings Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Mitsubishi Heavy Industries Ltd (7011)-エネルギー分野:企業M&A・提携分析
    Summary Mitsubishi Heavy Industries Ltd (MHI) is a manufacturer of heavy machinery. It offers a diverse range of products and services for power plants, chemical plants, environmental equipment, steel structures, industrial and general machinery, shipbuilding, aircraft, space systems and air-conditi …
  • Charles River Laboratories International Inc (CRL)-医療機器分野:企業M&A・提携分析
    Summary Charles River Laboratories International Inc (Charles River) is a contract research organization (CRO) that provides essential products and services to accelerate the research, drug discovery and development. It offers various basic research, drug discovery and safety assessment services. Th …
  • SK Innovation Co Ltd (096770):石油・ガス:M&Aディール及び事業提携情報
    Summary SK Innovation Co Ltd (SK Innovation) is an integrated energy and petrochemical company. It explores for and produces crude oil and natural gas; transportation of crude oil; and production of oil products such as gasoline and diesel. Through subsidiaries, the company carries out refining oper …
  • Quantum Fuel Systems LLC (QTWWQ):電力:M&Aディール及び事業提携情報
    Summary Quantum Fuel Systems LLC (Quantum) is a provider of natural gas storage systems, integration and vehicle system technologies. The company produces advanced and lightweight compressed natural gas (CNG) storage tanks and fully integrated natural gas storage systems and supplies these tanks to …
  • Ceapro Inc (CZO)-製薬・医療分野:企業M&A・提携分析
    Summary Ceapro Inc (Ceapro) is a biotechnology company which focuses on the development of extraction technology for use in the production of extracts and active ingredients from oats and other renewable plant resources. These extracts find application in therapeutic products for both humans and ani …
  • Kinpo Electronics Inc (2312):企業の財務・戦略的SWOT分析
    Kinpo Electronics Inc (2312) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • JSC Insurance Company Aldagi:企業の戦略・SWOT・財務情報
    JSC Insurance Company Aldagi - Strategy, SWOT and Corporate Finance Report Summary JSC Insurance Company Aldagi - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • CVS Health Corp (CVS):企業の財務・戦略的SWOT分析
    CVS Health Corp (CVS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Hudbay Minerals Inc:企業の戦略・SWOT・財務分析
    Hudbay Minerals Inc - Strategy, SWOT and Corporate Finance Report Summary Hudbay Minerals Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • The Restaurant Group Plc:企業の戦略・SWOT・財務情報
    The Restaurant Group Plc - Strategy, SWOT and Corporate Finance Report Summary The Restaurant Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • MEDITE Cancer Diagnostics Inc (MDIT):企業の財務・戦略的SWOT分析
    MEDITE Cancer Diagnostics Inc (MDIT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Dongfang Electric Corporation Ltd (1072):企業の財務・戦略的SWOT分析
    Dongfang Electric Corporation Ltd (1072) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Kadmon Holdings Inc (KDMN):企業の財務・戦略的SWOT分析
    Kadmon Holdings Inc (KDMN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • American International Group Inc:戦略・SWOT・企業財務分析
    American International Group Inc - Strategy, SWOT and Corporate Finance Report Summary American International Group Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • U.S. Stem Cell Inc (USRM):医療機器:M&Aディール及び事業提携情報
    Summary U.S. Stem Cell Inc (U.S. Stem Cell), formerly Bioheart, Inc, is a biotechnology company that focuses on the discovery, development and commercialization of cell based therapeutics products. The company repairs and replaces damaged or aged tissue, cells and organs and restoring their normal f …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆